Premium
Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens
Author(s) -
Bonvicini F,
Manaresi E,
Gallinella G,
Gentilomi GA,
Musiani M,
Zerbini M
Publication year - 2009
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.2009.02109.x
Subject(s) - parvovirus , serology , amniotic fluid , fetus , polymerase chain reaction , medicine , virology , prenatal diagnosis , cord blood , antibody , biology , immunology , pathology , obstetrics , pregnancy , virus , biochemistry , gene , genetics
Objective The purpose of our work was to examine the most reliable laboratory diagnosis of fetal parvovirus B19 infection in hydropic fetuses by evaluating the most appropriate clinical sample and laboratory test. Design B19 DNA detection in fetal samples and serological signs of B19 infection in the respective mothers. Samples collected between January 2000 and July 2008. Setting Microbiology, University of Bologna, Bologna, Italy. Samples One hundred thirty‐five fetal samples (58 fetal cord blood and 77 amniotic fluid samples) and 109 serum samples collected from 109 pregnant women. Methods Validated and certified in situ hybridisation assay (ISH) and polymerase chain reaction–enzyme‐linked immunosorbent assay (PCR‐ELISA) were performed on fetal samples to detect B19 DNA. B19‐specific antibodies were investigated in maternal serum samples by a commercial enzyme immunoassay. Main outcome measures Parvovirus B19 DNA detection in fetal specimens was analysed in relation to maternal serological signs of infection. Results Parvovirus B19 DNA was detected in 22.41% of fetal cord blood and 36.36% of amniotic fluid samples. A statistically significant difference was found between DNA detection by ISH (23.70%) and PCR‐ELISA (14.81%) ( P = 0.004). Only 11.76% of fetuses with virological diagnosis of B19 infection were from women with serological signs of acute/recent B19 infection. Conclusions Diagnosis of fetal parvovirus B19 infection cannot always rely on maternal serological investigations but rather on the virological analysis of fetal samples. Both fetal cord blood and amniotic fluid samples are suitable for diagnosis, but the detection of B19 DNA in the cells of amniotic fluid samples by ISH proved to be the most reliable diagnostic system.